Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections.
Free Radic Biol Med
; 156: 107-112, 2020 08 20.
Article
in English
| MEDLINE | ID: covidwho-620858
ABSTRACT
Ebselen is an organoselenium compound exhibiting hydroperoxide- and peroxynitrite-reducing activity, acting as a glutathione peroxidase and peroxiredoxin enzyme mimetic. Ebselen reacts with a multitude of protein thiols, forming a selenosulfide bond, which results in pleiotropic effects of antiviral, antibacterial and anti-inflammatory nature. The main protease (Mpro) of the corona virus SARS-CoV-2 is a potential drug target, and a screen with over 10,000 compounds identified ebselen as a particularly promising inhibitor of Mpro (Jin, Z. et al. (2020) Nature 582, 289-293). We discuss here the reaction of ebselen with cysteine proteases, the role of ebselen in infections with viruses and with other microorganisms. We also discuss effects of ebselen in lung inflammation. In further research on the inhibition of Mpro in SARS-CoV-2, ebselen can serve as a promising lead compound, if the inhibitory effect is confirmed in intact cells in vivo. Independently of this action, potential beneficial effects of ebselen in COVID-19 are ascribed to a number of targets critical to pathogenesis, such as attenuation of inflammatory oxidants and cytokines.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Azoles
/
Organoselenium Compounds
/
Viral Nonstructural Proteins
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
/
Antioxidants
Type of study:
Observational study
Language:
English
Journal:
Free Radic Biol Med
Journal subject:
Biochemistry
/
Medicine
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS